Ecuador vs Russian Federation: Previously treated cases tested for RR-/MDR-TB
Ecuador
97.0%
in 2024
Russian Federation
98.0%
in 2024
Ecuador rank
61st
Russian Federation rank
58th
Previously treated cases tested for RR-/MDR-TB over time
- Ecuador
- Russian Federation
How they compare
Russian Federation currently reports 98.0% against 97.0% in Ecuador, a difference of 1.0%.
The two have swapped places 5 times across 12 shared years of data; in 2007 it was Ecuador ahead.
Ecuador ranks 61st and Russian Federation ranks 58th of 180 countries.
Ecuador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 69.5% | 5.9% | 63.6% | Ecuador |
| 2010s | 85.6% | 36.6% | 49.0% | Ecuador |
| 2020s | 97.3% | 96.7% | 0.7% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Ecuador or Russian Federation?
- Russian Federation, at 98.0% against 97.0% in Ecuador as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Ecuador and Russian Federation?
- 1.0%, with Russian Federation ahead.
- How many years of comparable data are there for Ecuador and Russian Federation?
- 12 years are reported by both, from 2007 to 2024.
- How do Ecuador and Russian Federation rank globally for previously treated cases tested for rr-/mdr-tb?
- Ecuador ranks 61st and Russian Federation ranks 58th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.